RSLS (ReShape Lifesciences Inc) Rentabilitas dodolan miturut bathi reged

ReShape Lifesciences faces a liquidity shortage and a reliance on borrowings due to low returns. The production of weight loss systems relies on external component suppliers, with final assembly conducted in-house. The current gross margin reflects profitability dynamics, where 62.60 determines the current value of the metric. Equipment reliability is guaranteed by specialized white-glove delivery to clinics.
Rincian metrik komprehensif lan analitis ReShape Lifesciences Inc (RSLS)

Gross margin measures production efficiency by determining the portion of revenue remaining after covering direct costs. The metric is calculated as the ratio of gross profit to total revenue, demonstrating the business's sensitivity to raw material costs and logistics. By analyzing the gross profit margin, an investor can see how the supplier diversification of ReShape Lifesciences (RSLS) in the US minimizes customs risks, maintaining the stability of operating profitability.